Biomit secures significant round of investment funding

Reaffirms commitment to Electronic Data Capture (EDC) and European focus


Basel, Switzerland. Biomit Inc., a strategic e-clinical research partner, today announced the successful completion of the investment financing with CD-Venture GmbH, EKG Verwaltungs GmbH and DEWB (Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG), a bank-independent, stock quoted investment company based in Jena, Germany.

The significant funds raised will be primarily utilised to invest in the development of Biomit's own EDC solutions, particularly with regard to the customization of the technology for indication specific applications and the integration of an innovative electronic patient diary system, all due to be released within the next weeks.

Biomit's commitment to Europe remains paramount and additional resources will be allocated to improve the European infra-structure of Biomit's operations, including a UK based office to complete the extensive European network of both clinical trial project management, data management and marketing operations.

"With this significant external investment, Biomit is now well on track to position itself as a primary service provider in clinical trial management and to be the flagship partner of choice for EDC solutions. Biomit identifies the distinct needs and trends in the market and has positioned itself strategically to meet them both for today and the months and years to come" says Derek Brandt, Chief Executive Officer of Biomit Inc.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances